The revision of the EU Regulations on medicines for children and for rare diseases

Virtual Policy Dialogue

20 May 2021

12:00-13:30 CEST


The revision of the EU legislation on medicines for rare diseases and for children is one of the key actions of the Pharmaceutical Strategy for Europe. Our joint policy dialogue organised with the European Society for Paediatric Oncology, European Fair Pricing Network and the Association of European Cancer Leagues discussed concrete recommendations to deliver optimal treatment for children and those suffering from rare diseases, as ”one-size-fits-all” incentives do not lead to a sustainable and equitable pharmaceutical system.

On Social Media


Yannis NatsisΒ 

Policy Manager, Universal Access and Affordable Medicines

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!